SAGE PRO

Home / Research / Chambal Fertilisers and Chemicals Limited

SAGE PRO · ORIGINAL EQUITY RESEARCH

Chambal Fertilisers and Chemicals Limited — Q2 FY27 Results Analysis

Group earnings and cash claims must be assessed together

Published · Quarter Q2 FY27 · CHAMBLFERT

PeriodQ2 FY27
BasisIssuer disclosure
COMPANY-SPECIFIC GRAPHICAL SUMMARY

What the reported figures reveal

CHART 1

Investment Briefing — Q2 consolidated snapshot

Revenue₹7,000 crore
EBITDA₹900 crore
PAT₹632 crore
CHART 2

Q2 operating revenue comparison

Q2 FY26₹6,413 crore
Q2 FY27₹7,000 crore
CHART 3

Consolidated Q2 margins

EBITDA margin12.87%
PAT margin9.03%
CHART 4

Q2 urea segment growth

Q2 FY26₹3,317 crore
Q2 FY27₹4,629 crore
ORIGINAL RESEARCH INSIGHTS

Investment findings and watch points

RESEARCH INSIGHT

Group earnings and cash claims must be assessed together

Issuer-disclosed financial or operational measure, with period and reporting basis stated in the accompanying analysis.

Watch: Reconcile the comparable measure in the next issuer filing.

RESEARCH INSIGHT

Revenue rose nine percent year on year

Issuer-disclosed financial or operational measure, with period and reporting basis stated in the accompanying analysis.

Watch: Reconcile the comparable measure in the next issuer filing.

RESEARCH INSIGHT

EBITDA and PAT reflect different cost layers

Issuer-disclosed financial or operational measure, with period and reporting basis stated in the accompanying analysis.

Watch: Reconcile the comparable measure in the next issuer filing.

RESEARCH INSIGHT

Urea strengthened despite the external environment

Issuer-disclosed financial or operational measure, with period and reporting basis stated in the accompanying analysis.

Watch: Reconcile the comparable measure in the next issuer filing.

FULL PUBLISHED RESEARCH

Earnings and management commentary analysis

Quarter ended 30 September 2026 | Stance: WATCH | Urea, traded fertilisers, crop inputs and newly commissioned technical ammonium nitrate. The quarter's central issue is the contrast between a stronger urea segment and pressured traded fertiliser economics. The newly commercialised TAN plant adds an industrial earnings driver, but its operating history is too short to assume steady-state margins.

Decision dashboard

Q2 FY27 indicatorReported valueInterpretation
Consolidated operating revenue₹7,000 crore, +9% YoY [S1]Headline growth conceals segment divergence
Consolidated EBITDA₹900 crore; margin 12.87% [S1]Urea strength offset pressure elsewhere
Consolidated PAT₹632 crore; margin 9.03% [S1]Earnings positive; subsidy timing remains important
Urea segment revenue₹4,629 crore versus ₹3,317 crore [S1]Core business improved markedly
Complex fertiliser revenue₹1,978 crore versus ₹2,721 crore [S1]Material contraction in traded products
TAN revenue₹67 crore [S1]Initial contribution after commercial start
Total receivables₹4,818 crore at 30 September [S1]Subsidy funding is a major cash-conversion variable

Six decision takeaways: (1) Q2 consolidated revenue rose 9%, but the mix shifted sharply toward urea. (2) Urea segment EBIT was ₹668 crore on ₹4,629 crore revenue; its efficiency is the main stabiliser. (3) Complex fertiliser EBIT was only ₹78 crore on ₹1,978 crore revenue, a 3.97% margin [S1]. (4) TAN began commercial production in August and reported ₹67 crore of quarterly revenue; ramp-up economics remain unproven. (5) Subsidy receivables of ₹4,157 crore made up most of total quarter-end receivables, linking liquidity to government disbursements. (6) A fourth urea plant is preparatory, not an approved operating asset or certain capex commitment.

Chapter 1 — Thirty-second investor decision and valuation discipline

Chambal combines a large domestic urea manufacturing franchise with traded complex fertilisers, crop protection, specialty nutrients, seeds and an emerging industrial chemicals business. It operates in a policy-sensitive sector where volumes, raw-material costs, regulated subsidy formulas and timing of government payments all influence financial outcomes. The company also has distribution scale: its November investor presentation cites more than 93,000 retailers and around 4,976 dealers across 18 states [S2].

The stance is WATCH. Q2 demonstrated resilience through urea operations, but the contraction in complex fertiliser revenue and margin highlights how different the segment economics are. A stock valuation would need to reflect not just reported consolidated EBITDA but the durability of urea earnings, potential subsidy working-capital requirements, the TAN project's achievable utilisation and any capital commitment to a future fourth urea unit. The supplied issuer documents do not establish a contemporaneous market price, share count or defensible cost of capital for a numerical price target. None is invented.

The central upside proposition is that efficient urea production, established distribution and a successful TAN ramp-up create multiple sources of earnings. The principal downside is that regulated pricing, weather, import costs and government receivables can absorb cash or pressure margins despite solid reported profits. Investors should distinguish operational execution from exogenous subsidy and commodity effects.

Decision tests: Track segment EBIT, not only group EBITDA. Measure subsidy collection against new subsidy receivables. Monitor TAN utilisation and customer acceptance. Treat the fourth urea project as a conditional option until the board and government approvals, project costs and funding plan are disclosed.

Chapter 2 — Q2 and H1 financials; standalone versus consolidated

Management reported Q2 FY27 standalone revenue from operations of ₹7,000 crore versus ₹6,413 crore in Q2 FY26, standalone EBITDA of ₹901 crore at a 12.87% margin and standalone PAT of ₹635 crore, up 6% YoY [S1]. The corresponding consolidated numbers were revenue ₹7,000 crore, EBITDA ₹900 crore and PAT ₹632 crore, with a 9.03% PAT margin. The close revenue figures should not obscure the distinct PAT and EBITDA bases.

Financial measureQ2 FY27Basis
Operating revenue₹7,000 croreConsolidated, management call [S1]
EBITDA₹900 croreConsolidated [S1]
EBITDA margin12.87%Consolidated [S1]
PAT₹632 croreConsolidated [S1]
PAT margin9.03%Consolidated [S1]
Standalone EBITDA₹901 croreStandalone [S1]
Standalone PAT₹635 croreStandalone [S1]

For H1 FY27, consolidated operating revenue was ₹12,027 crore, EBITDA ₹1,752 crore and PAT ₹1,156 crore [S1]. The company described consolidated H1 EBITDA growth of 9% and a 133-basis-point margin improvement. On a standalone basis, H1 PAT was ₹1,338 crore, up 8%, and H1 EBITDA was ₹1,752 crore. The difference between standalone and consolidated H1 PAT is meaningful and must not be glossed over. Joint-venture and group accounting effects can influence the reconciliation; a formal attribution requires the complete financial schedules.

The earnings-quality question is whether improved urea efficiency and margins are sustainable after raw-material and subsidy adjustments. EBITDA is not cash flow, and PAT is not the amount of subsidy actually collected. The reported Q2 profit should be considered alongside ₹4,157 crore of outstanding subsidy receivables at September-end. A strong income statement and a large working-capital claim can coexist.

Financial tests: Compare consolidated and standalone results without mixing bases. Reconcile H1 group profit with the joint-venture contribution. Compare subsidy accrued and subsidy cash received. Do not annualise the TAN start-up quarter or assume its initial margin represents a full-cycle run rate.

Chapter 3 — Segment economics, volumes and distribution

The urea business recorded Q2 production of 9.13 lakh metric tonnes and sales of 8.0 lakh metric tonnes [S1]. Segment revenue was ₹4,629 crore, compared with ₹3,317 crore in the prior-year quarter, and segment EBIT reached ₹668 crore at a reported 14.44% margin. Management described the urea plants as operating at high efficiency, making them the key earnings stabiliser in a difficult input-cost environment. Production exceeding sales in one quarter is not automatically a problem; inventory movement and seasonality require context.

Complex fertilisers were much weaker. Q2 sales volume was 3.04 lakh tonnes; segment revenue fell to ₹1,978 crore from ₹2,721 crore, while EBIT was ₹78 crore at a 3.97% margin [S1]. Management attributed substantial pricing pressure to imported nutrient-based subsidy and NPK fertilisers in the analyst discussion. The traded business's procurement timing, freight, global input prices and subsidy mechanics create a different risk profile from domestic urea manufacturing.

The crop protection, specialty nutrients and seeds segment reported ₹325 crore revenue versus ₹374 crore a year earlier and EBIT of ₹87 crore, a 26.76% segment margin [S1]. The high reported segment margin is attractive, but revenue contracted in a difficult agricultural environment. A high margin on lower sales is not proof of accelerating growth. The company said it launched 13 products during H1 against 14 planned for FY27 and continued demonstrations, farmer meetings and soil-testing outreach.

The TAN segment recorded ₹67 crore revenue and ₹12 crore EBIT at a reported 17.97% margin after its commercial start [S1]. The issuer presentation identifies 240,000 metric tonnes of TAN manufacturing capacity [S2]. Installed capacity, actual utilisation and sales are distinct measures. It is too early to infer a stable annual EBIT run rate from the first partial quarter.

Segment watchpoints: Monitor urea output and efficiency; complex fertiliser procurement and segment margin; crop-input sales against weather and channel conditions; TAN utilisation, offtake and unit cost. Avoid combining tonnes, rupees and percentage margins into one undifferentiated growth claim.

Chapter 4 — Execution milestones, product pipeline and analyst challenges

The TAN project reached commercial production during Q2. Management said weak nitric acid and ammonium nitrate solutions were operating at optimum levels, while high-density ammonium nitrate was being ramped up [S1]. Customer acceptance was described as encouraging. The meaningful next milestone is repeat offtake at economic utilisation, not merely a commissioning announcement. An industrial plant can generate start-up revenue before demonstrating its full cost structure.

Chambal is also preparing for a possible fourth urea plant under the National Investment Policy for Urea 2026. The presentation refers to land acquisition, site-enabling work and an in-principle gas-supply approval, while environmental clearance and other approvals remain in progress [S2]. Management said a final investment decision depends on government approvals, project economics and board approval [S1]. This should be treated as a contingent project, not as guaranteed new capacity or an approved capital commitment.

In crop inputs, the company discussed a TERI research partnership and ten proposed jointly developed products, with five targeted for FY2028–29 and the remainder later [S1]. These dates are management's intended product-development pathway, not realised revenue. Regulatory registration, field efficacy, channel adoption and commercial pricing will determine the actual returns. The company reported over 2,800 farmer meetings and crop seminars, around 3,600 demonstrations and more than 38,000 soil samples analysed in the quarter [S1]. Outreach activity is useful leading evidence, but it is not the same as profitable sales conversion.

In the Q&A, an investor asked which segment absorbed input-cost pressure. Management identified traded complex fertilisers as the main pressure point, while urea efficiency supported margins [S1]. This is the central operating challenge to test next quarter. Another challenge is whether TAN ramp-up can offset cyclical weakness in agricultural trading without imposing new working-capital strain.

Milestone tests: Require a dated TAN utilisation and sales trajectory. Seek formal fourth-plant approval and project economics before capitalising the opportunity in valuation. Compare product launches with actual distribution and sales. Measure whether channel initiatives lift crop-input revenue after weather normalises.

Chapter 5 — Subsidy cash, receivables, capital and payback

The most important balance-sheet observation in the Q2 call was the receivables position. Management reported roughly ₹3,300 crore of subsidy received during the quarter and ₹4,818 crore of total receivables at September 30, comprising ₹4,157 crore subsidy receivables and ₹661 crore market debtors [S1]. These are large amounts relative to quarterly earnings. Subsidy receipts improve liquidity, but the remaining subsidy balance can still absorb funding until collected.

Working-capital measureQ2 FY27Source
Subsidy cash received during quarterApproximately ₹3,300 croreManagement call [S1]
Subsidy receivables at September-end₹4,157 croreManagement call [S1]
Market debtors at September-end₹661 croreManagement call [S1]
Total receivables₹4,818 croreManagement call [S1]

The company's revenue recognition and subsidy receipts are not necessarily contemporaneous. An investor should therefore monitor receivable days, disbursement cadence and the financing cost of bridging subsidy claims. The difference between subsidy receivables and market debtors also matters: these are distinct counterparties and collection mechanisms.

The issuer presentation reports FY26 net debt to equity of 0.01%, ROE of 20.83% and ROCE of 25.36% [S2]. These are FY26 historical snapshot metrics, not September 2026 balance-sheet ratios. They must not be republished as Q2 debt or returns. This briefing does not invent a September-end debt balance, operating cash flow or TAN payback period. The full H1 cash-flow statement and detailed capital-expenditure schedules are required to quantify free cash flow and project returns.

The TAN project adds an industrial asset with a different working-capital and ramp-up profile from the mature urea plants. The potential fourth urea plant could be much more capital intensive, but no definitive approved investment value is established in the extracted evidence. A responsible valuation keeps that option conditional.

Capital tests: Track subsidy receipts against accruals; compare market debtor ageing; reconcile operating cash with EBITDA and PAT; request TAN capex and utilisation economics; distinguish maintenance investment from any approved new urea capacity.

Chapter 6 — Bull, base and bear conditional outcomes

These are evidence-based conditions rather than numerical forecasts or price targets.

Bull: Urea plants retain high efficiency and stable subsidy economics, traded fertiliser margin recovers as global costs and procurement conditions normalise, crop-input demand rebounds, and TAN reaches commercially meaningful utilisation with satisfactory unit margins. Subsidy collections keep pace with accruals. A future fourth urea project is approved only at attractive economics. The bull case would be falsified by persistently weak complex fertiliser margins, slow TAN offtake or deteriorating receivable collections.

Base: Urea continues to support consolidated earnings, while complex fertiliser trading remains cyclical. Crop-input products recover gradually as agricultural conditions change. TAN contributes increasing but initially modest revenue; working-capital needs remain sensitive to subsidy timing. Group margins fluctuate with mix rather than expand in a straight line. A sharp improvement in segment cash conversion could strengthen this case; sustained margin deterioration would weaken it.

Bear: Imported nutrient and freight costs stay elevated, complex fertiliser margins remain thin, weak rainfall or farm economics limit crop-input demand, and subsidy disbursements lag accruals. TAN utilisation grows slowly and the fourth urea project creates capital pressure before returns are visible. The bear case would be challenged by improved subsidy collections, stronger traded fertiliser EBIT and sustained TAN offtake.

ScenarioRequired observationInvestment implication
BullBetter traded margins, healthy TAN ramp and prompt subsidy collectionsRevisit sustainable earnings and valuation
BaseUrea resilience with uneven secondary segmentsMaintain watch; require cash-flow confirmation
BearWorking-capital build and weaker segment economicsDemand substantial valuation protection

No unsupported commodity price path, future subsidy rate, earnings per share or share-price target is embedded in these scenarios. They provide a testable framework for the next two quarters.

Chapter 7 — Investor action plan and monitoring scorecard

Action: WATCH. The company's Q2 results warrant attention because urea segment economics strengthened despite challenging traded fertiliser conditions. The decision should be based on repeatable segment profit and cash conversion, not simply the consolidated revenue growth rate.

Next quarter: Record urea production, sales and segment EBIT on a consistent basis. Compare complex fertiliser revenue and margin with Q2's ₹1,978 crore and 3.97% baseline. Monitor crop-input sales against Q2's ₹325 crore and the seasonal/weather context. For TAN, seek operating rate, sales volumes, pricing and customer acceptance rather than extrapolating ₹67 crore of start-up revenue into a full-year forecast.

Cash discipline: Update subsidy receipts, subsidy receivables and market debtors separately. Reconcile total receivables with ₹4,818 crore at September-end. Monitor working-capital funding costs, operating cash flow and capex from the statutory filings. Do not treat ₹3,300 crore of subsidy cash received as profit.

Capital allocation: Require board-approved economics before assigning material value to a fourth urea plant. Track TAN commissioning and utilisation against installed capacity of 240,000 tonnes, without treating capacity as sales. Monitor whether new crop-input products generate revenue and contribution profit after distribution expenses.

Risks: Volatile gas and imported fertiliser costs, subsidy delays, weather-driven demand, low-margin traded products, project ramp-up execution, regulatory approvals and potential working-capital funding requirements. Catalysts: Better complex fertiliser margins, sustained urea efficiency, TAN offtake, crop-input sales recovery and faster subsidy collection.

Original issuer sources: ; S2 — Chambal Fertilisers earnings presentation for Q2 and H1 FY27, filed with BSE 3 November 2026. Financial figures and management targets are explicitly distinguished. The scenarios are conditional research analysis, not company guidance. No unsupported valuation, debt, project payback or future subsidy assumption is presented.

Additional company evidence

CHART 5

Q2 complex fertiliser revenue

Q2 FY26₹2,721 crore
Q2 FY27₹1,978 crore
CHART 6

Q2 crop inputs revenue

Q2 FY26₹374 crore
Q2 FY27₹325 crore
CHART 7

Q2 segment EBIT

Urea₹668 crore
Complex₹78 crore
Crop inputs₹87 crore
TAN₹12 crore
CHART 8

Q2 segment EBIT margins

Urea14.44%
Complex3.97%
Crop inputs26.76%
TAN17.97%
SOURCE REFERENCES

Original disclosures and investor presentations

  1. Issuer disclosure

Related research and comparisons

Other published Q2 FY27 reports

This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.